Combination Immunotherapy
Combination Immunotherapy is a therapeutic strategy within cancer immunology and immuno-oncology pharmacotherapy that integrates two or more distinct immunotherapeutic agents or modalities to enhance anti-tumor immune responses through complementary or synergistic mechanisms.
7.1K
Publications
547.3K
Citations
48.8K
Authors
6.1K
Institutions
Publications per year
2017–2026
4.3K
Variants
Combination Immuno-oncology Therapy
Children
Adoptive T Cell Therapy CombinationsBiomarker-guided Combination ImmunotherapyBispecific Antibody CombinationsCancer Vaccine CombinationsCheckpoint Inhibitor CombinationsChimeric Antigen Receptor T Cell Combination TherapyCytokine CombinationsDual Immune Checkpoint InhibitionImmune Checkpoint Blockade CombinationsNeoantigen Vaccine Combinations
7.1K
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore et al. · New England Journal of Medicine · 2010 · 5.5K citations · Full text
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Harriet M. Kluger, Margaret K. Callahan et al. · New England Journal of Medicine · 2013 · 4.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2019 · 3.7K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +14
1–5 of 7.1K
48.8K
48
h-index
45
h-index
Memorial Sloan Kettering Cancer Center, United States
73 publications · 41.7K citations
44
h-index
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
97 publications · 32.6K citations
43
h-index
35
h-index
1–5 of 48.8K
6.1K
Memorial Sloan Kettering Cancer Center
New York, United States
108 h-index
1.6K publications
465.4K citations
Dana-Farber Cancer Institute
Boston, United States
104 h-index
1.1K publications
161.9K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
98 h-index
2.6K publications
217.9K citations
Bristol-Myers Squibb (United States)
New York, United States
78 h-index
817 publications
246.1K citations
Harvard University
Cambridge, United States
76 h-index
724 publications
94.9K citations
National Cancer Institute
Bethesda, United States
76 h-index
870 publications
90.8K citations

Cornell University
Ithaca, United States
73 h-index
626 publications
392.5K citations
Inserm
Paris, France
66 h-index
714 publications
136.3K citations
1–8 of 6.1K
725 publications · 50.8K citations
109
h-index
267 publications · 33.1K citations
98
h-index
JITC · 308 publications · 20.4K citations
75
h-index
Repository · 387 publications · 18K citations
69
h-index
148 publications · 15.8K citations
64
h-index
1–5